Safety, Pharmacokinetics, and Immunogenicity of Obiltoxaximab After Intramuscular Administration to Healthy Humans
Clinical Pharmacology in Drug Development - United States
doi 10.1002/cpdd.410
Full Text
Open PDFAbstract
Available in full text
Date
November 10, 2017
Authors
Publisher
Wiley